Decline depth
-27.0%
From rolling 252-day high of $14.76, 174d ago.
Past the 20% Watch threshold.
-27.0%
from rolling 252-day high of $14.76 set 2026-02-27 · 174d ago
Current
$10.78
Decline depth
-27.0%
Decline σ
7.6σ
TFC
1/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$XRAY landed on the list 2026-03-08, down 25.5% from its 52-week high that day — now down -27.0%.
That's 10.9 percentage points deeper than the day it joined. It bottomed 43.9% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-09 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
XRAY qualifies for the Amber List on decline depth.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
7.6σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.37% per day).
Past the ≥6σ Amber threshold.
The structural read
What price action says about XRAY.
XRAY qualifies for the Amber List on decline depth — down -27.0% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 7.6σ over 20 bars.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 1 (red).
Earnings on file: 2026-05-05. Tiering is unaffected by earnings dates — listings reflect price structure only.
Questions about XRAY
What people ask.
Why is XRAY on Broken Stocks?
XRAY qualifies for the Amber List on decline depth. It is down -27.0% from its rolling 252-day high of $14.76, set on 2026-02-27 — 174d ago.
Is XRAY a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. XRAY is down -27.0% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is XRAY a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is XRAY trading inside its 52-week range?
At $10.78, XRAY sits 17.8% of the way from its 52-week low ($9.41) to its 52-week high ($17.09). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has XRAY been declining?
The current 27.0% decline accrued over 174d, which annualizes to roughly -56.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does XRAY compare to its sector?
There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 34 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — XRAY's decline is shallower than the sector median.
Does XRAY's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.